Marine Drugs · 2010 · 63 citations · 22 references
Life SciencesMarine BiologyPharmacologyApoptosisChemotherapyMarine MicrobiologyApoptosis In CancerApoptosis ResistanceCell DeathCytotoxic ChemotherapyMarine Cell CultureMarine Drug DiscoveryAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia TherapyAnticancer Compound ScreeningAnticancer Drug ResistanceAnticancer Marine CompoundsAnticancer Mechanism Of ActionAntimicrobial Marine CompoundsMarine-derived Anticancer Compounds
The potential of marine benthic cyanobacteria as a source of anticancer drug candidates was assessed in a screen for induction of cell death (apoptosis) in acute myeloid leukemia (AML) cells. Of the 41 marine cyanobacterial strains screened, more than half contained cell death-inducing activity. Several strains contained activity against AML cells, but not against non-malignant cells like hepatocytes and cardiomyoblasts. The apoptotic cell death induced by the various strains could be distinguished by the role of caspase activation and sensitivity to the recently detected chemotherapy-resistance-associated prosurvival protein LEDGF/p75. One strain (M44) was particularly promising since its activity counteracted the protective effect of LEDGF/p75 overexpressed in AML cells, acted synergistically with the anthracycline anticancer drug daunorubicin in AML cells, and protected cardiomyoblasts against the toxic effect of anthracyclines. We conclude that culturable benthic marine cyanobacteria from temperate environments provide a promising and hitherto underexploited source for novel antileukemic drugs.
22
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Marine cyanobacteria—a prolific source of natural products
Adam M. Burja, Bernard Banaigs, Eliane Abou‐Mansour et al. · Tetrahedron · 2001 · 840 citations
Lydia Campos, JP Rouault, Odile Sabido et al. · Blood · 1993 · 783 citations · Full text
Medicine, Hematology, Oncology +14